LaGray is the first fully-integrated generic pharmaceutical manufacturer in West Africa. We produce both active pharmaceutical ingredients and finished dosage forms. 

Our focus is on drugs for treating endemic diseases such as HIV-AIDS, opportunistic infections, malaria, tuberculosis and parasitic, bacterial and fungal infections.

The high burden of disease in sub-Saharan Africa contributes to >70% of the mortality in the region and account for massive economic losses. Although there are currently effective drugs for treating most of these diseases, the issue is affordability and availability.
 

LaGray is pioneering the push toward self-sufficiency in healthcare in sub-Saharan Africa.

Learn more>>

 

 

                                                                                           

                                                                                  LaGray Chemical Company Partners with Poverty Reduction Foundation (CSRwire). NSAWAM, GHANA - Africa focused pharmaceutical company, LaGray, today announced a partnership with the Rural Women Skills and Development Foundation (RWSDF) of Ghana. More>>

LaGray Chemical Company of Chicago is using a $4.9 million OPIC loan to construct a pharmaceutical manufacturing facility in Nsawam, Ghana, where it will produce for sale, active pharmaceutical ingredients...More>> 

Springboard Selects African Focused pharmaceutical Manufacturing Business, LaGray Chemical Company  to Present at the Silicon Valley Women's Venture Capital Forum More>>